Unable to display view head.php file not found.
 
 

James A. Reiffel, MD - Novel Oral Anticoagulants - Figure 36

Pre-defined Populations in ROCKET AF

The previous Figure showed the results of the ITT analysis (ie, the results were analyzed on the basis of which drug each patient was prescribed).  However there were 2 further pre-defined analyses (shown in this Figure):

  • safety-on-treatment (all people in the ITT population who got at least one dose of the drug) and
  • per-protocol (all patients in the safety population who did not have a major protocol violation, which was the overwhelming majority of the patients).[97]

 Reiffel JA. Am J Med 2013; 126: 00-00.

Complete references for all slides

References

[97] Patel MR, Mahaffey KW, Garg J, et al; the ROCKET AF Steering Committee, for the ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.

Unable to display view foot.php file not found.